Welcome!

News Feed Item

SHL Telemedicine Reports Second Quarter 2014 Financial Results

-- Revenue increased 39.2% to USD 10.3 million (USD 7.4 million in Q2 2013)

TEL AVIV, Israel and ZURICH, Aug. 20, 2014 /PRNewswire/ -- SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN, OTCPK: SMDCY), a leading provider and developer of advanced personal telemedicine solutions, today announced results for the second quarter and six months ended 30 June 2014.

Erez Alroy, Co-CEO of SHL, commented: "We have seen good momentum in our businesses leading to significantly improved financial performance for the period, even with the increased investments in our expansion initiatives. Expansion into new markets beyond Israel and Germany, based on our global smartheart™ platform, remains a key priority for SHL's growth strategy.

"In the US, we are progressing with our plans to launch our products and services, while in India we have made first steps in rolling out our telemedicine solution. In addition, since receiving approval in March to commence marketing activities in Japan, our smartheart™ platform has been accepted by over 20 leading Japanese clinics.

"We have gone through a lengthy process of receiving regulatory and marketing approvals for the smartheart™ platform in several major territories. The global interest we are witnessing is very encouraging and we are excited by the opportunities it may bring."

Financial Highlights
During the second quarter 2014, revenues increased considerably primarily due to the growth in the Company's German business, following the acquisition of almeda. Even with the increased investments in geographical expansion, SHL's financial performance has improved significantly with improved gross profit and operating results.

Revenues for the quarter grew by 39.2% (32.4% at constant exchange rates*) and amounted to USD 10.3 million compared to USD 7.4 million in Q2 2013.

For the half year revenues grew by 44.1% (37.2% at constant exchange rates) and amounted to USD 20.9 million compared to USD 14.5 million in the first half of 2013.

Gross profit for the quarter amounted to USD 5.8 million (56.3% of revenues) compared to USD 3.9 million (52.7% of revenues) in Q2 2013. Gross profit for the half year amounted to USD 11.7 million (56.0% of revenues) compared to a gross profit of USD 7.6 million (52.4% of revenues) in the first half of 2013.

EBITDA and EBIT for the half year and second quarter improved significantly over the adjusted EBITDA and EBIT of 2013, which included a one-time item lowering the general and administrative expenses.

For the quarter, EBITDA amounted to USD 1.7 million (16.5% of revenues) with EBIT at USD 0.2 million (1.9% of revenues) compared with an adjusted EBITDA and LBIT of USD 0.6 million and USD 0.7 million in the second quarter 2013.

For the half year, EBITDA amounted to USD 3.7 million (17.7% of revenues) with an EBIT of USD 0.6 million (2.9% of revenues), compared with an adjusted EBITDA of USD 0.5 million (3.4% of revenues) and an LBIT of USD 1.9 million in the first half of 2013.

Unadjusted EBITDA and EBIT for the second quarter 2013 amounted to USD 1.7 million and USD 0.4 million, respectively with EBITDA and EBIT for the first half of 2013 amounting to USD 3.1 million and USD 0.6 million, respectively.

Net Income for the quarter and half year was USD 0.1 million, or USD 0.01 per share, compared to an adjusted net loss of USD 1.1 million, for the second quarter 2013 and USD 2.8 million for the first half of 2013. Unadjusted net profit for the second quarter and first half of 2013 amounted to USD 0.1 million (USD 0.00 per share) and USD 0.3 million (USD 0.03 per share), respectively.

Cash used in operations for the quarter and half year amounted to USD 0.9 million and USD 3.3 million, respectively. Excluding USD 5.2 million received from Philips in the first quarter of 2013, which was the last payment related to the Raytel transaction, cash used in operations during the quarter and half year 2013 amounted to USD 0.8 million and USD 2 million. The decrease in operating cash flow is the result of one–time working capital requirements at almeda, for which SHL received USD 2.9 million upfront at the end of 2013. Cash, cash equivalents and marketable securities amounted to USD 21.8 million at June 30, 2014.

Balance sheet included total assets at 30 June 2014 of USD 106.3 million with shareholders' equity amounting to USD 68.8 million (64.7% of balance sheet) compared to total assets of USD 108.5 million with shareholders' equity amounting to USD 68.9 million at 31 December 2013.

SHL Telemedicine – consolidated key figures – Q2 2014

in USD million
(except per
share amounts)

Q2 2014

Q2 2013

% change

Q2 2014
(constant
currency)

% change

Revenues

10.3

7.4

39.2%

9.8

32.4%

Gross profit

5.8

3.9

48.7%

5.5

41.0%

%

56.3%

52.7%


56.1%


EBIT/(LBIT)

0.2

0.4

(50.0%)

0.2

(50.0%)

%

1.9%

5.4%


2.0%


EBITDA

1.7

1.7

0.0%

1.6

(5.9%)

%

16.5%

23.0%


16.3%


Net income
(loss)

0.1

0.1

n.a.

0.1

n.a.

Basic EPS
(LPS)

0.01

0.00

n.a.

0.01

n.a.

SHL Telemedicine – consolidated key figures - H1 2014

in USD million
(except per
share amounts)

H1 2014

H1 2013

% change

H1 2014
(constant
currency)

% change

Revenues

20.9

14.5

44.1%

19.9

37.2%

Gross profit

11.7

7.6

53.9%

11.2

47.4%

%

56.0%

52.4%


56.3%


EBIT/(LBIT)

0.6

0.6

0.0%

0.6

0.0%

%

2.9%

4.1%


3.0%


EBITDA

3.7

3.1

19.4%

3.5

12.9%

%

17.7%

21.4%


17.5%


Net income
(loss)

0.1

(0.3)

n.a.

0.1

n.a.

Basic EPS
(LPS)

0.01

(0.03)

n.a.

0.01

n.a.

*Constant currency - In order to enable meaningful comparison between the results, they are also presented at constant currency exchange rates. These are calculated by translating the 2014 results using the average 2013 exchange rates instead of the current period exchange rates.

Management believes that this presentation enables a more meaningful comparison between the periods due to the significant fluctuations in NIS/USD/EUR exchange rates.

Revenues by geographic distribution – Q2 14


Israel

Germany


USD m

% of total

USD m

% of total

Q2 2014

6.1

59.2%

4.2

40.8%

Q2 2013

5.8

78.4%

1.6

21.6%

Q2 2014 (in constant
currency)

5.9

60.2%

3.9

39.8%

% change in constant
currency

1.7%


143.8%



Revenues by geographic distribution – H1 14


Israel

Germany


USD m

% of total

USD m

% of total

H1 2014

12.2

58.4%

8.7

41.6%

H1 2013

11.4

78.6%

3.1

21.4%

H1 2014 (in constant
currency)

11.6

58.3%

8.3

41.7%

% change in constant
currency

1.8%


167.7%


Conference Call, today, 4.00 pm CET / 10.00am ET 
SHL will hold a call to discuss the Q2 results today at 4.00 pm CET / 10.00am ET. Erez Alroy, Co-CEO, and Eran Antebi, CFO, will host the call. Dial-in numbers are as follows:

From Europe

+41 (0)58 310 50 00

From UK

+44 (0)203 059 58 62

From U.S.A.

Toll free: +1 866 291 41 66

From Israel

Toll free: 1 80 921 44 27


Local: +972 3763 1173

Slides and our half year report are available at
http://www.shl-telemedicine.com/about-us/investorrelations/financial-reports-pres-2014/

IR Agenda 2014
November 19, 2014    Q3 Results

About SHL Telemedicine

SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. The Company operates in Israel, Germany, India and the United States in one business segment, Telemedicine services. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957) and has an ADR program listed over-the counter; Symbol: SMDCY. For more information please visit our web site at www.shl-telemedicine.com.

For further information please contact:

Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements.

 

Balance-Sheets (USD thousands)

30.6.2014

30.6.2013

31.12.2013


Unaudited

Unaudited

Audited

Cash and cash equivalents

8,154

9,457

8,732

Restricted cash

1,365

-

-

Short term investments

12,301

18,091

19,661

Trade receivables

14,764

12,495

10,479

Inventory

1,628

475

869

Other current assets

8,193

6,596

8,014

Current Assets

46,405

47,114

47,755





Non-Current Assets

11,403

12,322

11,632





Property and equipment, net

15,700

15,125

15,982





Intangible assets, net

32,793

23,292

33,146

Total Assets

106,301

97,853

108,515





Credit from banks and current maturities

10,643

9,117

10,477

Deferred revenues

521

110

330

Trade payables

1,969

1,016

1,433

Other accounts payable

4,236

3,768

4,568

Other liabilities

1,526

-

2,504

Current liabilities

18,895

14,011

19,312





Long-term loans

16,496

18,965

18,205

Deferred revenues

1,218

1,272

1,283

Employee benefit liabilities

875

985

805

Non-current liabilities

18,589

21,222

20,293





Total liabilities

37,484

35,233

39,605

Equity:




Issued capital

31

31

31

Additional paid-in capital

95,037

94,692

95,014

Treasury shares

(2,579)

(2,956)

(2,774)

Foreign currency translation reserve

6,213

3,622

6,148

Capital reserve for available-for-sale 
     investments and actuarial gains

1,175

892

1,633

Accumulated deficit

(31,060)

(33,661)

(31,142)

Total equity

68,817

62,620

68,910

Total liabilities and equity

106,301

97,853

108,515

 

 

Statements of Income
(USD thousands, except per share data)

Q2 14

Q2 13

H1 14

H1 13

2013


Unaudited

Unaudited

Unaudited

Unaudited

Audited

Revenues

10,274

7,408

20,917

14,548

29,674







Depreciation and amortization

562

551

1,166

1,122

2,127

Cost of revenues

3,947

2,963

8,007

5,859

11,607

Gross Profit

5,765

3,894

11,744

7,567

15,940







Research and development costs, net

645

577

1,242

1,013

2,206

Selling and marketing expenses

2,987

2,328

5,719

4,679

8,787

General and administrative expenses

2,063

583

4,347

1,291

10,341

Gain from almeda acquisition and other income

(137)

-

(137)

-

(8,492)

Operating income

207

406

573

584

3,098







Financial income

511

141

704

474

1,072

Financial expenses

(370)

(407)

(614)

(1,052)

(2,631)

Income before taxes on income

348

140

663

6

1,539

Taxes on income (Tax benefit)

269

82

581

293

(693)







Net income (loss)

79

58

82

(287)

2,232







Basic and diluted income (loss) per share

0.01

0.00

0.01

(0.03)

0.22


Other Comprehensive income not to be 
     reclassified to profit or loss in subsequent 
     periods:






Foreign currency translation reserve

301

620

65

1,562

4,088

Actuarial gain

-

-

-

-

233


301

620

65

1,562

4,321

Other Comprehensive income to be reclassified 
     to profit or loss in subsequent periods






Transfer to the statement of income in respect of 
     available-for-sale investments

(489)

 

13

(545)

 

(19)

146

Gain (loss) on available-for-sale investments

(87)

19

87

63

406


(576)

32

(458)

44

552













Total comprehensive income (loss)

(196)

710

(311)

1,319

7,105







 

 

Statements of Cash Flows (USD thousands)

Q2 2014

Q2 2013

H1 2014

H1 2013

2013


Unaudited

Unaudited

Unaudited

Unaudited

Audited

Net income (loss)

79

58

82

(287)

2,232

Adjustment required to reconcile net income 
     (loss) to net cash provided by (used in) 
     operating activities

(964)

 

 

(822)

(3,340)

 

 

3,459

400

Net Cash provided by (used in) Operating 
     Activities

(885)

(764)

(3,258)

3,172

2,632







Purchase of property and equipment

(480)

(315)

(863)

(918)

(2,200)

Investment in intangible assets

(380)

(501)

(778)

(986)

(1,878)

Restricted cash

(1,367)

-

(1,367)



Acquisition of almeda

-

-

-

-

2,920

Proceeds from sale of property and 
     equipment

-

 

14

-

 

14

29

Purchase of short-term investments

(3,130)

(2,665)

(5,056)

(3,113)

(8,511)

Proceeds from sale of  short-term investments

10,085

 

905

12,529

 

1,654

6,402

Net Cash provided by (used in) Investing 
     Activities

4,728

(2,562)

4,465

(3,349)

(3,238)







Proceeds from exercise of options

60

101

65

141

486

Short-term bank credit, net

(714)

461

-

218

1,053

Payment of long-term loans

(998)

(804)

(1,867)

(1,580)

(3,267)

Treasury shares purchased

-

-

-

(36)

(36)

Net Cash used in Financing Activities

(1,652)

(242)

(1,802)

(1,257)

(1,764)

Effect of exchange rate changes on cash and 
     cash equivalents

24

 

56

17

 

278

489

Increase (decrease) in cash and cash 
     equivalents

2,215

(3,512)

(578)

(1,156)

(1,881)

Cash and cash equivalents at the beginning of 
     the period

5,939

12,969

8,732

10,613

10,613

Cash and Cash equivalents at the end of the 
     period

8,154

9,457

8,154

9,457

8,732

 

SOURCE SHL Telemedicine Ltd.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
SYS-CON Events announced today that Ryobi Systems will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Ryobi Systems Co., Ltd., as an information service company, specialized in business support for local governments and medical industry. We are challenging to achive the precision farming with AI. For more information, visit http:...
SYS-CON Events announced today that SIGMA Corporation will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. uLaser flow inspection device from the Japanese top share to Global Standard! Then, make the best use of data to flip to next page. For more information, visit http://www.sigma-k.co.jp/en/.
SYS-CON Events announced today that Daiya Industry will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Daiya Industry specializes in orthotic support systems and assistive devices with pneumatic artificial muscles in order to contribute to an extended healthy life expectancy. For more information, please visit https://www.daiyak...
Today traditional IT approaches leverage well-architected compute/networking domains to control what applications can access what data, and how. DevOps includes rapid application development/deployment leveraging concepts like containerization, third-party sourced applications and databases. Such applications need access to production data for its test and iteration cycles. Data Security? That sounds like a roadblock to DevOps vs. protecting the crown jewels to those in IT.
SYS-CON Events announced today that B2Cloud will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. B2Cloud specializes in IoT devices for preventive and predictive maintenance in any kind of equipment retrieving data like Energy consumption, working time, temperature, humidity, pressure, etc.
Automation is enabling enterprises to design, deploy, and manage more complex, hybrid cloud environments. Yet the people who manage these environments must be trained in and understanding these environments better than ever before. A new era of analytics and cognitive computing is adding intelligence, but also more complexity, to these cloud environments. How smart is your cloud? How smart should it be? In this power panel at 20th Cloud Expo, moderated by Conference Chair Roger Strukhoff, paneli...
SYS-CON Events announced today that NetApp has been named “Bronze Sponsor” of SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. NetApp is the data authority for hybrid cloud. NetApp provides a full range of hybrid cloud data services that simplify management of applications and data across cloud and on-premises environments to accelerate digital transformation. Together with their partners, NetApp em...
Most of the time there is a lot of work involved to move to the cloud, and most of that isn't really related to AWS or Azure or Google Cloud. Before we talk about public cloud vendors and DevOps tools, there are usually several technical and non-technical challenges that are connected to it and that every company needs to solve to move to the cloud. In his session at 21st Cloud Expo, Stefano Bellasio, CEO and founder of Cloud Academy Inc., will discuss what the tools, disciplines, and cultural...
What is the best strategy for selecting the right offshore company for your business? In his session at 21st Cloud Expo, Alan Winters, U.S. Head of Business Development at MobiDev, will discuss the things to look for - positive and negative - in evaluating your options. He will also discuss how to maximize productivity with your offshore developers. Before you start your search, clearly understand your business needs and how that impacts software choices.
SYS-CON Events announced today that Interface Corporation will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Interface Corporation is a company developing, manufacturing and marketing high quality and wide variety of industrial computers and interface modules such as PCIs and PCI express. For more information, visit http://www.i...
SYS-CON Events announced today that Keisoku Research Consultant Co. will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Keisoku Research Consultant, Co. offers research and consulting in a wide range of civil engineering-related fields from information construction to preservation of cultural properties. For more information, vi...
SYS-CON Events announced today that MIRAI Inc. will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. MIRAI Inc. are IT consultants from the public sector whose mission is to solve social issues by technology and innovation and to create a meaningful future for people.
SYS-CON Events announced today that Fusic will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Fusic Co. provides mocks as virtual IoT devices. You can customize mocks, and get any amount of data at any time in your test. For more information, visit https://fusic.co.jp/english/.
SYS-CON Events announced today that N3N will exhibit at SYS-CON's @ThingsExpo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. N3N’s solutions increase the effectiveness of operations and control centers, increase the value of IoT investments, and facilitate real-time operational decision making. N3N enables operations teams with a four dimensional digital “big board” that consolidates real-time live video feeds alongside IoT sensor data a...
Mobile device usage has increased exponentially during the past several years, as consumers rely on handhelds for everything from news and weather to banking and purchases. What can we expect in the next few years? The way in which we interact with our devices will fundamentally change, as businesses leverage Artificial Intelligence. We already see this taking shape as businesses leverage AI for cost savings and customer responsiveness. This trend will continue, as AI is used for more sophistica...